A probiotic supplement boosts response to cancer immunotherapy

Lisa Derosa^{1

2

3

4}, Laurence Zitvogel^{5

6

7

8

9}

Affiliations

¹ Gustave Roussy, ClinicObiome, Villejuif, France. deros.lisa@gmail.com.
² INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France. deros.lisa@gmail.com.
³ Departement of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. deros.lisa@gmail.com.
⁴ Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. deros.lisa@gmail.com.
⁵ Gustave Roussy, ClinicObiome, Villejuif, France.
⁶ INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
⁷ Departement of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
⁸ Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France.
⁹ Université Paris-Saclay, Le Kremlin Bicêtre, France.

Comment

Lisa Derosa et al. Nat Med. 2022 Apr.

. 2022 Apr;28(4):633-634.

doi: 10.1038/s41591-022-01723-4.

Lisa Derosa^{1

2

3

4}, Laurence Zitvogel^{5

6

7

8

9}

¹ Gustave Roussy, ClinicObiome, Villejuif, France. deros.lisa@gmail.com.
² INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France. deros.lisa@gmail.com.
³ Departement of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. deros.lisa@gmail.com.
⁴ Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. deros.lisa@gmail.com.
⁵ Gustave Roussy, ClinicObiome, Villejuif, France.
⁶ INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
⁷ Departement of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
⁸ Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France.
⁹ Université Paris-Saclay, Le Kremlin Bicêtre, France.

No abstract available

Comment on

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.

1. Mountzouris, K. C., McCartney, A. L. & Gibson, G. R. Br. J. Nutr. 87, 405–420 (2002). - PubMed
1. Isa, K. et al. Hum. Exp. Toxicol. 35, 818–832 (2016). - DOI - PubMed
1. Dizman, N. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01694-6 (2022). - DOI - PubMed
1. Seki, H. et al. Pediatr. Int. 45, 86–90 (2003). - DOI - PubMed
1. Stoeva, M. K. et al. Gut Microbes 13, 1–28 (2021). - DOI - PubMed